Lv1
30 积分 2023-05-19 加入
Afatinib boosts CAR-T cell antitumor therapeutic efficacy via metabolism and fate reprogramming
3小时前
待确认
Rapid Response to Penpulimab Combined With Anlotinib and Chemotherapy in a Thoracic SMARCA4‐UT Without PD‐L1 Expression: A Case Report and Review of Literature
23天前
已完结
Poly(ADP-ribose) Polymerase-1 (PARP1)-based Dual Inhibitors Targeting Cancer Synthetic Lethality (2022-present): Advances and Perspectives
1个月前
已完结
CD2 augmentation enhances CAR-T-cell efficacy via immunological synapse remodeling and T-cell exhaustion mitigation
1个月前
已完结
CD2 augmentation enhances CAR-T-cell efficacy via immunological synapse remodeling and T-cell exhaustion mitigation
1个月前
已完结
T-cell-antigen recognition and the immunological synapse
1个月前
已完结
EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function
1个月前
已完结
SMARCA4: Implications of an Altered Chromatin-Remodeling Gene for Cancer Development and Therapy
1个月前
已完结
Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods
2个月前
已完结
Prior chemotherapy deteriorates T-cell quality for CAR T-cell therapy in B-cell non-Hodgkin’s lymphoma
2个月前
已完结
皖公网安备34019202002308
